Crossref journal-article
Elsevier BV
European Journal of Pharmacology (78)
Bibliography

Dustan Sarazan, R., Crumb, W. J., Beasley, C. M., Emmick, J. T., Ferguson, K. M., Strnat, C. A., & Sausen, P. J. (2004). Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5—sildenafil, tadalafil, and vardenafil. European Journal of Pharmacology, 502(3), 163–167.

Authors 7
  1. R. Dustan Sarazan (first)
  2. William J. Crumb (additional)
  3. Charles M. Beasley (additional)
  4. Jeffrey T. Emmick (additional)
  5. Kenneth M. Ferguson (additional)
  6. Christine A. Strnat (additional)
  7. Peter J. Sausen (additional)
References 33 Referenced 28
  1. 10.1067/mhj.2002.125804 / Am. Heart J. / Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management by Anderson (2002)
  2. 10.1161/01.RES.83.5.560 / Circ. Res. / Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit by Barry (1998)
  3. Cialis® Package Insert, 2003. Indianapolis, Indiana and Bothell, Washington: Eli Lilly and ICOS.
  4. 10.1016/S0022-5347(17)34871-1 / J. Urol. / Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study by Feldman (1994)
  5. 10.1161/01.CIR.102.3.275 / Circulation / Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current by Geelen (2000)
  6. 10.1007/BF00656997 / Pflügers Arch. / Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches by Hamill (1981)
  7. 10.1111/j.1469-7793.1998.003bi.x / J. Physiol. / Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels by Herzberg (1998)
  8. 10.1016/0006-291X(90)92168-Y / Biochem. Biophys. Res. Commun. / Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle by Ignarro (1990)
  9. 10.1016/j.clpt.2003.11.178 / Clin. Pharmacol. Ther. / A definitive study of the effects of PDE-5 inhibitors on cardiac repolarization in middle-age males by Ilson (2004)
  10. 10.1254/jjp.76.31 / Jpn. J. Pharmacol. / Inhibition of delayed rectifier K+ current by dofetilide and E-4031 differentially affects electrical cardiac responses to vagus stimulation in anesthetized dogs by Imamura (1998)
  11. {'key': '10.1016/j.ejphar.2004.09.005_bib11', 'first-page': 'H1891', 'article-title': 'Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q–T phenotype', 'volume': '278', 'author': 'Jeron', 'year': '2000', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q–T phenotype by Jeron (2000)
  12. 10.1097/01.ju.0000075055.34506.59 / J. Urol. / Erectile dysfunction in the cardiac patient: how common and should we treat? by Kloner (2003)
  13. {'key': '10.1016/j.ejphar.2004.09.005_bib13', 'first-page': '418', 'article-title': 'Effect of renal impairment on the single-dose pharmacokinetics of vardenafil 20 mg, a selective PDE5 inhibitor, for the treatment of erectile dysfunction', 'volume': '22', 'author': 'Klotz', 'year': '2002', 'journal-title': 'Pharmacotherapy (Abstr.)'} / Pharmacotherapy (Abstr.) / Effect of renal impairment on the single-dose pharmacokinetics of vardenafil 20 mg, a selective PDE5 inhibitor, for the treatment of erectile dysfunction by Klotz (2002)
  14. 10.1056/NEJM200006153422407 / New Engl. J. Med. / Erectile dysfunction by Lue (2000)
  15. 10.1046/j.1540-8167.2001.00411.x / J. Cardiovasc. Electrophysiol. / Problems of heart rate correction in assessment of drug-induced QT interval prolongation by Malik (2001)
  16. 10.2165/00002018-200124050-00001 / Drug Saf. / Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling by Malik (2001)
  17. 10.1073/pnas.210244497 / Proc. Natl. Acad. Sci. / A structural basis for drug-induced long QT syndrome by Mitcheson (2000)
  18. 10.1046/j.1365-2125.2000.00245.x / Br. J. Clin. Pharmacol. / Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir by Muirhead (2000)
  19. {'key': '10.1016/j.ejphar.2004.09.005_bib19', 'first-page': '788', 'article-title': 'The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG', 'volume': '286', 'author': 'Rampe', 'year': '1998', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG by Rampe (1998)
  20. 10.1016/S0008-6363(02)00846-5 / Cardiovasc. Res. / Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development by Redfern (2003)
  21. 10.1111/j.1540-8159.1998.tb00148.x / PACE / Taking the ‘idio’ out of ‘idiosyncratic’: predicting torsades de pointes by Roden (1998)
  22. 10.2337/diabetes.45.9.1197 / Diabetes / Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes by Saldeen (1996)
  23. 10.1536/ihj.39.183 / Jpn. Heart J. / Effect of E4031, a class III antiarrhythmic drug, on ischemia- and reperfusion-induced arrhythmias in isolated rat hearts by Shinmura (1998)
  24. 10.1161/01.CIR.102.10.1178 / Circulation / Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 by Splawski (2000)
  25. 10.1038/sj.bjp.0700989 / Br. J. Pharmacol. / The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes by Suessbrich (1997)
  26. 10.1016/j.cardiores.2003.12.026 / Cardiovasc. Res. / Pharmacology of cardiac potassium channels by Tamargo (2004)
  27. 10.7326/0003-4819-122-9-199505010-00009 / Ann. Intern. Med. / Electrophysiologic mechanisms of the long QT interval syndromes and torsades de pointes by Tan (1995)
  28. {'key': '10.1016/j.ejphar.2004.09.005_bib28', 'first-page': '77', 'article-title': 'Drugs, QT interval abnormalities and ventricular arrhythmias', 'volume': '13', 'author': 'Thomas', 'year': '1994', 'journal-title': 'Adverse Drug React. Toxicol. Rev.'} / Adverse Drug React. Toxicol. Rev. / Drugs, QT interval abnormalities and ventricular arrhythmias by Thomas (1994)
  29. 10.1126/science.7604285 / Science / HERG, a human inward rectifier in the voltage-gated potassium channel family by Trudeau (1995)
  30. {'key': '10.1016/j.ejphar.2004.09.005_bib30', 'series-title': "Physicians' Desk Reference", 'first-page': '2534', 'author': 'Viagra® Package Insert', 'year': '2001'} / Physicians' Desk Reference by Viagra® Package Insert (2001)
  31. {'key': '10.1016/j.ejphar.2004.09.005_bib31', 'first-page': '19', 'article-title': 'Prevalence of cardiovascular risk factors in erectile dysfunction', 'volume': '5', 'author': 'Walczak', 'year': '2002', 'journal-title': 'J. Gend.-Specif. Med.'} / J. Gend.-Specif. Med. / Prevalence of cardiovascular risk factors in erectile dysfunction by Walczak (2002)
  32. 10.1073/pnas.91.8.3438 / Proc. Natl. Acad. Sci. / A family of potassium channel genes related to eag in Drosophila and mammals by Warmke (1994)
  33. {'key': '10.1016/j.ejphar.2004.09.005_bib33', 'first-page': '116', 'article-title': 'Towards a drug concentration effect relationship for QT prolongation and torsades de pointes', 'volume': '5', 'author': 'Webster', 'year': '2002', 'journal-title': 'Curr. Opin. Drug Discov. Dev.'} / Curr. Opin. Drug Discov. Dev. / Towards a drug concentration effect relationship for QT prolongation and torsades de pointes by Webster (2002)
Dates
Type When
Created 20 years, 11 months ago (Sept. 29, 2004, 11:08 a.m.)
Deposited 6 years, 7 months ago (Feb. 3, 2019, 6:58 a.m.)
Indexed 1 year, 9 months ago (Nov. 15, 2023, 11:20 a.m.)
Issued 20 years, 11 months ago (Oct. 1, 2004)
Published 20 years, 11 months ago (Oct. 1, 2004)
Published Print 20 years, 11 months ago (Oct. 1, 2004)
Funders 0

None

@article{Dustan_Sarazan_2004, title={Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5—sildenafil, tadalafil, and vardenafil}, volume={502}, ISSN={0014-2999}, url={http://dx.doi.org/10.1016/j.ejphar.2004.09.005}, DOI={10.1016/j.ejphar.2004.09.005}, number={3}, journal={European Journal of Pharmacology}, publisher={Elsevier BV}, author={Dustan Sarazan, R. and Crumb, William J. and Beasley, Charles M. and Emmick, Jeffrey T. and Ferguson, Kenneth M. and Strnat, Christine A. and Sausen, Peter J.}, year={2004}, month=oct, pages={163–167} }